209 related articles for article (PubMed ID: 20800692)
21. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether.
Prada J; Müller S; Bienzle U; Kremsner PG
J Antimicrob Chemother; 1996 Jul; 38(1):95-102. PubMed ID: 8858461
[TBL] [Abstract][Full Text] [Related]
22. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
23. Dose responses of proveblue methylene blue in an experimental murine cerebral malaria model.
Dormoi J; Pradines B
Antimicrob Agents Chemother; 2013 Aug; 57(8):4080-1. PubMed ID: 23669389
[No Abstract] [Full Text] [Related]
24. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
[TBL] [Abstract][Full Text] [Related]
25. Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy.
Chukwuocha UM; Fernández-Rivera O; Legorreta-Herrera M
J Ethnopharmacol; 2016 Dec; 193():517-523. PubMed ID: 27693771
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Desgrouas C; Pradines B
Antimicrob Agents Chemother; 2013 Jul; 57(7):3412-4. PubMed ID: 23612202
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.
Iwalokun BA
Afr Health Sci; 2008 Mar; 8(1):25-35. PubMed ID: 19357729
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J
Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004
[TBL] [Abstract][Full Text] [Related]
29. Experimental cerebral malaria is suppressed by disruption of nucleoside transporter 1 but not purine nucleoside phosphorylase.
Niikura M; Inoue S; Mineo S; Yamada Y; Kaneko I; Iwanaga S; Yuda M; Kobayashi F
Biochem Biophys Res Commun; 2013 Mar; 432(3):504-8. PubMed ID: 23402751
[TBL] [Abstract][Full Text] [Related]
30. Rocaglates as dual-targeting agents for experimental cerebral malaria.
Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA.
Ding Y; Xu W; Zhou T; Liu T; Zheng H; Fu Y
Parasitology; 2016 Oct; 143(12):1672-80. PubMed ID: 27574013
[TBL] [Abstract][Full Text] [Related]
32. Artemisone effective against murine cerebral malaria.
Waknine-Grinberg JH; Hunt N; Bentura-Marciano A; McQuillan JA; Chan HW; Chan WC; Barenholz Y; Haynes RK; Golenser J
Malar J; 2010 Aug; 9():227. PubMed ID: 20691118
[TBL] [Abstract][Full Text] [Related]
33. Nanotized curcumin-benzothiophene conjugate: A potential combination for treatment of cerebral malaria.
Ghosh A; Banerjee T
IUBMB Life; 2020 Dec; 72(12):2637-2650. PubMed ID: 33037778
[TBL] [Abstract][Full Text] [Related]
34. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
[TBL] [Abstract][Full Text] [Related]
35. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
[TBL] [Abstract][Full Text] [Related]
36. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
37. Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune.
Gbotosho GO; Happi CT; Woranola O; Abiodun OO; Sowunmi A; Oduola AM
Parasitol Res; 2012 Feb; 110(2):895-9. PubMed ID: 21826489
[TBL] [Abstract][Full Text] [Related]
38. Azadirachta indica ethanolic extract protects neurons from apoptosis and mitigates brain swelling in experimental cerebral malaria.
Bedri S; Khalil EA; Khalid SA; Alzohairy MA; Mohieldein A; Aldebasi YH; Seke Etet PF; Farahna M
Malar J; 2013 Aug; 12():298. PubMed ID: 23984986
[TBL] [Abstract][Full Text] [Related]
39. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
